List of Tables
TABLE 1. IL-17 INHIBITORS FOR PSORIASIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY BRODALUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY BRODALUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY IXEKIZUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY IXEKIZUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY SECUKINUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY SECUKINUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY CYCLOSPORINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY CYCLOSPORINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY METHOTREXATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY BIWEEKLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY BIWEEKLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY MONTHLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY MONTHLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY CHILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY CHILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 120. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 121. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 130. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 131. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 132. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 133. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 134. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 135. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 138. CANADA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 139. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 140. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 141. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 150. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 151. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 158. MEXICO IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 241. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 242. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 243. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 248. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 249. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 252. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 253. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 256. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 257. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 260. GERMANY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 261. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 262. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 263. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 268. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 269. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 272. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 273. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 274. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 275. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 276. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 277. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 280. FRANCE IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY THERAPEUTIC REGIMEN, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 301. ITALY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 302. ITALY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 303. ITALY IL-17 INHIBITORS FOR PSORIASIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 3